We recently sat down with members of the SGD Pharma and PAI teams to talk about how they are turning an ambitious plan into reality.

PAI recently completed the sale of ELITech Group, a global manufacturer of in-vitro diagnostics, to Bruker, a prominent international life science research and diagnostics solutions provider.

260 in-person attendees, 37 speakers and 17 CEOs joined PAI’s 2024 Annual General Meeting, which brought together our investors, portfolio company leaders and PAI colleagues.

It’s been a busy year for PAI. As we approach the end of 2023, we’ve been reflecting on some of the highlights – across our funds and portfolio, in our team, our achievements in ESG and charitable efforts.

Tropicana Brands Group, the global portfolio of iconic juice brands, was formed following a carve-out of the portfolio from our partners PepsiCo – a complex process to which PAI Partners is uniquely suited.

PAI’s 2023 Annual General Meeting recently took place and brought together our investors, portfolio company CEOs and PAI colleagues.